SCHN 2018 Proxy Statement

Compensation of Executive Officers Summary Compensation Table The following table sets forth certain information concerning compensation of the NEOs during the fiscal years ended August 31, 2016, 2017, and 2018. Name and Principal Position Year Salary ($) Stock Awards ($) (1) Non-Equity Incentive Plan Compensation ($) (2) Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) (3) All Other Compensation ($) (4) Total ($) Tamara L. Lundgren President and Chief Executive Officer 2018 1,104,231 3,499,941 4,290,000 110,184 84,179 9,088,535 2017 1,014,615 3,499,930 4,025,309 244,373 54,212 8,838,439 2016 1,000,000 4,299,969 1,519,570 218,051 32,963 7,070,553 Richard D. Peach Senior Vice President, Chief Financial Officer and Chief of Corporate Operations 2018 663,904 959,982 1,097,005 — 24,436 2,745,327 2017 634,108 959,932 831,823 — 24,213 2,450,076 2016 618,000 959,935 451,410 — 30,622 2,059,967 Michael R. Henderson Senior Vice President and Co-President, AMR and CSS 2018 564,404 749,947 932,601 — 24,459 2,271,411 2017 539,365 749,921 702,064 — 25,022 2,016,372 2016 525,000 749,955 349,669 — 43,981 1,668,605 Steven G. Heiskell Senior Vice President and Co-President, AMR 2018 482,305 749,947 622,204 — 13,403 1,867,859 2017 460,861 749,921 524,174 — 13,060 1,748,016 2016 438,462 749,955 259,754 — 12,972 1,461,143 Jeffrey Dyck (5) Senior Vice President and Co-President, CSS 2018 464,135 514,979 582,516 — 23,386 1,585,016 2016 433,000 514,947 217,160 — 22,053 1,187,160 (1) Represents the aggregate grant date fair value of stock awards granted during each of the years computed in accordance with FASB ASC Topic 718. These amounts reflect the grant date fair value and may not correspond to the actual value that will be realized by the NEOs. Stock awards consist of RSUs and LTIP performance shares. The grant date fair value of the RSUs is equal to the value of the underlying shares based on the closing market price of the Company’s Class A common stock on the Nasdaq Global Select Market on the grant date. The grant date fair value of the LTIP performance share awards under the CFROI and ROCE metrics is calculated by multiplying the target number of shares issuable under the award by the closing market price of the Company’s Class A common stock on the Nasdaq Global Select Market on the grant date. The grant date fair value of the LTIP performance share awards under the TSR metric is estimated using a Monte-Carlo simulation model. If the maximum number of shares issuable under LTIP performance share awards had been used in this calculation in lieu of the target number of shares, the amounts in the table for fiscal 2018 would have been: Ms. Lundgren, $5,249,894; Mr. Peach, $1,439,967; Mr. Henderson, $1,124,914; Mr. Heiskell, $1,124,914; and Mr. Dyck, $772,470. (2) Non-Equity Incentive Plan Compensation in fiscal 2018 consists of amounts paid under the AICP and the APBP. See “Compensation Discussion and Analysis – Annual Incentive Programs.” (3) Represents changes in the actuarial present value of accumulated benefits under the Pension Retirement Plan and the SERBP for each of the years presented using the same pension plan measurement date used for financial statement reporting purposes. (4) Includes for fiscal 2018, Company matching contributions of $10,800 to the account of each NEO under the 401(k) Plan. Includes for fiscal 2018, amounts paid for out-of-pocket medical expenses under the supplemental executive medical benefits plan to Ms. Lundgren of $58,001. Includes for fiscal 2018, premiums paid for life, disability and other insurance in the following amounts: Ms. Lundgren, $5,409; Mr. Peach, $3,582; Mr. Henderson, $3,047; Mr. Heiskell, $2,603; and Mr. Dyck, $2,507. Includes for fiscal 2018, automobile allowance and fuel purchase fringe benefits in the following amounts: Ms. Lundgren, $9,969; Mr. Peach, $10,054; Mr. Henderson, $10,613; and Mr. Dyck, $10,079. (5) Mr. Dyck was not a named executive officer in fiscal 2017. Notice of Annual Meeting of Shareholders and 2018 Proxy Statement | 53